Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-3884

ABSTRACT: Gene expression of humanised keratin 12 in mouse cornea. A comparison between wild-type, heterozygous and homozygous genotypes.

PROVIDER: E-MTAB-3884 | ExpressionAtlas | 2020-07-13

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-3884-analysis-methods.tsv	Tabular
	E-MTAB-3884-analytics.tsv	Tabular
	E-MTAB-3884-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-3884-configuration.xml	Xml
	E-MTAB-3884-g3_g1-mvaPlot.png	Other

Items per page:

1 - 5 of 31

Similar Datasets

Gene expression of humanised keratin 12 in mouse cornea. A comparison between wild-type, heterozygous and homozygous genotypes.

Project description:Gene expression of humanised keratin 12 in mouse cornea. A comparison between wild-type, heterozygous and homozygous genotypes.

| PRJEB10848 | ENA

E-MTAB-8443

Project description:Comparison of gene expression in the brain between Slc18b1 knockout and wild type mice

2020-01-06 | E-MTAB-8443 | ExpressionAtlas

E-GEOD-54931

Project description:Comparison of gene expression pattern between Wild-type and Setd2 knockout mESCs [Affymetrix]

2014-10-28 | E-GEOD-54931 | ExpressionAtlas

E-GEOD-7179

Project description:Comparison of gene expression data between wild-type and DM1-affected undifferentiated hES cells.

2025-01-24 | E-GEOD-7179 | ExpressionAtlas

E-GEOD-54705

Project description:Comparison of transcriptomes between N-stress tolerant and sensitive genotypes

2015-08-26 | E-GEOD-54705 | ExpressionAtlas

A feasibility study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with metastatic colorectal cancer.

Project description:Interventions: Patients receive FOLFIRI with bevacizumab fixed 5mg/kg. (Treatment will be continued unless the disease progression, unacceptable toxicity, or consent withdrawal.) Definision of UGT1A1 polymorphisms groups: The homozygous group is patient with homozygous genotype of UGT1A1*28/*28 or UGT1A1*6/*6, with combined heterozygous genotypes of UGT1A1*28 and UGT1A1*6. The heterozygous group is patient with heterozygous genotype of either UGT1A1*28 or UGT1A1*6. The wild group is patients with no UGT1A1*28 and UGT1A1*6 mutation. CPT-11 dosage is wild and heterozygous:CPT-11 150mg/m2 homozygous:CPT-11 100mg/m2 Primary outcome(s): 1)incidence of adverse events 2)frequency of severe toxicity Study Design: Single arm Non-randomized

| 2620216 | ecrin-mdr-crc

E-GEOD-17157

Project description:Expression data from E18.5 Igf1 -/- (homozygous mutant) and Igf1+/+ (normal wild type control) mouse lungs

2015-07-07 | E-GEOD-17157 | ExpressionAtlas

A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.

Project description:Interventions: Administraion of CPT-11 is twice for 4 weeks on days 1 and 15. CPT-11 is reconstituted in >=250 mL of normal saline or 5% dextrose in water and infuse 90min on day 1 for pharmacokinetics, and 90min over on day15. CPT-11 adjusted dosage is determined from 50,75,100,125 or 150mg/sqm in the heterozygous group and the homozygous group by continual reassessment method. CPT-11 dosage is fixed at 150mg/sqm in the wild group.Definision of UGT1A1 polymorphisms groups: The homozygous group is patient with homozygous genotype of UGT1A1*28/*28 or UGT1A1*6/*6, with combined heterozygous genotypes of UGT1A1*28 and UGT1A1*6. The heterozygous group is patient with heterozygous genotype of either UGT1A1*28 or UGT1A1*6. The wild group is patients with no UGT1A1*28 and UGT1A1*6 mutation. Primary outcome(s): Maximum tolerated dose for the heterozygous group and the homozygous group, respectively. Incidence rate of dose limiting toxicities for the wild group. Study Design: Single arm Non-randomized

| 2616019 | ecrin-mdr-crc

E-GEOD-52220

Project description:Expression data from E11.5 mouse branchial arch 1 (BA1) - comparison between Ezh2lox/lox and Wnt1Cre Ezh2lox/lox embryos

2015-07-27 | E-GEOD-52220 | ExpressionAtlas

E-MTAB-3988

Project description:Gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma

2015-11-10 | E-MTAB-3988 | ExpressionAtlas